Cargando…

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines

OBJECTIVE: Ankaferd hemostat is the first topical hemostatic agent about the red blood cell–fibrinogen relations tested in the clinical trials. Ankaferd hemostat consists of standardized plant extracts including Alpinia officinarum, Glycyrrhiza glabra, Thymus vulgaris, Urtica dioica, and Vitis vinif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turk, Seyhan, Malkan, Umit Yavuz, Ghasemi, Mehdi, Hocaoglu, Helin, Mutlu, Duygu, Gunes, Gursel, Aksu, Salih, Haznedaroglu, Ibrahim Celalettin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336193/ https://www.ncbi.nlm.nih.gov/pubmed/28293423 http://dx.doi.org/10.1177/2050312116689519

Ejemplares similares

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

Ankaferd hemostat: from molecules to medicine
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2020)

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat
por: HAZNEDAROĞLU, İbrahim Celalettin, et al.
Publicado: (2020)

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids
por: Koluman, Ahmet, et al.
Publicado: (2016)

Endothelial Cells, Ankaferd Hemostat, and Estradiol
por: Ardıçoğlu, Yasemin, et al.
Publicado: (2016)

Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case
por: Malkan, Umit Yavuz, et al.
Publicado: (2016)

Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

NK-cell dysfunction of acute myeloid leukemia in relation to the renin–angiotensin system and neurotransmitter genes
por: Turk, Seyhan, et al.
Publicado: (2022)

Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia
por: Ghasemi, Mehdi, et al.
Publicado: (2019)

Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content
por: Beyazit, Fatma, et al.
Publicado: (2020)

The Factors Affecting Early Death in Newly Diagnosed APL Patients
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine
por: Okay, Mufide, et al.
Publicado: (2019)

In vitro analysis of the renin–angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus
por: Turk, Can, et al.
Publicado: (2020)

Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines
por: Turk, Seyhan, et al.
Publicado: (2023)

Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission
por: Aydın, Mürüvvet Seda, et al.
Publicado: (2017)

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System
por: Akbal, Erdem, et al.
Publicado: (2013)

Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma
por: Ghasemi, Mehdi, et al.
Publicado: (2016)

Combination of Novoseven and Feiba in Hemophiliac Patients with Inhibitors
por: Malkan, Umit Yavuz, et al.
Publicado: (2018)

Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

In Vitro Efficacy of the Ankaferd Galenic Hemostatic Extract as a Germicidal Agent
por: METİN, Bayram, et al.
Publicado: (2016)

Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach
por: Koçak, Engin, et al.
Publicado: (2019)

Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
por: OKAY, Müfide, et al.
Publicado: (2019)

A New Candidate as a Hemostatic Agent for Difficult Situations During Variceal Bleeding: Ankaferd Blood Stopper
por: Ozaslan, Ersan, et al.
Publicado: (2011)

The Prognosis of Adult Burkitt’s Cell Leukemia in Real-Life Clinical Practice
por: Malkan, Ümit Yavuz, et al.
Publicado: (2016)

Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases
por: Koluman, Ahmet, et al.
Publicado: (2017)

Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis
por: Gunes, Hafize Nalan, et al.
Publicado: (2016)

The impact of JAK/STAT inhibitor ruxolitinib on the genesis of lymphoproliferative diseases
por: TÜRK, Can, et al.
Publicado: (2019)

Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem cell transplantation
por: KARATAŞ, Ayşe, et al.
Publicado: (2022)

Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model
por: Huri, Emre, et al.
Publicado: (2013)

Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide
por: Turk, Seyhan, et al.
Publicado: (2020)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level
por: Huri, Emre, et al.
Publicado: (2016)

The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients
por: KARATAŞ, Ayşe, et al.
Publicado: (2021)

Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874
por: Çınar, Olgu Erkin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e4p2k7o4mrm4q78g7b1cdglq4t